Long-Term Follow-Up of Donor Chimerism and Tolerance After Human Liver Transplantation
Rosa Ayala(Hospital Universitario 12 De Octubre), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Enriqueta Albízua(Hospital Universitario HM Madrid), Almudena Crooke(Universidad Complutense de Madrid), Florinda Gilsanz(Hospital Universitario HM Madrid), J.C. Meneu, Enrique Moreno(Research Institute Hospital 12 de Octubre), Almudena Moreno, Silvia Grande(Research Institute Hospital 12 de Octubre)
Cited by 19
Related Papers
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523